亚太地区肿瘤专家小组《德曲妥珠单抗相关不良反应的监测和管理指南》解读

Interpretation of "Guidelines for Monitoring and Management of Adverse Reactions Associated with Trastuzumab" issued by the Asia-Pacific Oncology Expert Group

TANG Xueqin，ZHENG Xueyan，WANG Qiaoling，LIU Li，LI Ben*Chongqing Health Center for Women and Children/Women and Children′s Hospital of Chongqing Medical University，Chongqing 401147 China*Corresponding Author LI Ben，E-mail：2019111189@stu.cqmu.edu.cn

Abstract This article interpreted "Guidelines for Monitoring and Management of Adverse Reactions Associated with Trastuzumab" issued by the Asia-Pacific Oncology Expert Group in August 2023.It aimed to provide practical suggestions for clinical medical staff to monitor and manage adverse events associated with trastuzumab.

Keywords breast cancer;trastuzumab deruxtecan;adverse reactions;human epidermal growth factor receptor 2;targeted therapy;nursing

摘要 对2023年8月亚太地区肿瘤专家小组发布的《德曲妥珠单抗相关不良反应的监测和管理指南》进行解读，旨在为临床医务人员监测和管理德曲妥珠单抗相关不良事件提供实用建议。（剩余15738字）